Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CPLANE1 antisense RNA 1 (CPLANE1-AS1) is a long non-coding RNA (lncRNA) that is transcribed in the antisense direction to the protein-coding CPLANE1 gene, located at chromosome 5q35.1[1][5]. Like other antisense lncRNAs, CPLANE1-AS1 has the potential to regulate the expression of its associated sense gene (CPLANE1) through RNA-RNA, RNA-DNA, or RNA-protein interactions that modulate transcription or translation, predominantly via cis-regulatory mechanisms[2][4][6]. There is currently no evidence that CPLANE1-AS1 has been established as a therapeutic target, nor are there known drugs or biomarkers associated directly with this RNA molecule. Most scientific and clinical research focus for this genomic region is on the role of the sense gene, CPLANE1, in ciliogenesis and ciliopathy syndromes such as Joubert syndrome, not on CPLANE1-AS1[3]. The function and disease relevance of CPLANE1-AS1 specifically have not been characterized in detail to date[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CPLANE1 antisense RNA 1 (CPLANE1-AS1).